I can't say why he's been silent but his blogs and tweets have done more harm that good, imo. And that's because he had set up expectations that have continually fell short. Gerald seems to be a smart guy but there has been a disconnect between what he has said and what actually has been happening. As the company prepares to up list, would it be a bad thing to implement a new CEO who has had more experience guiding a biotech than Gerald? Could those investment firms Gerald has spoken about advised Gerald that Amarantus would be better off with a CEO that has an established biotech track record? Either way, it is imperative that Amarantus up list. The company is dying on the OTC vine. And if Gerald truly wants to make Amarantus a thriving biotech, he needs to do what is best for the company. If he believes he is the one to guide the company, then so be it.